Search details
1.
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Br J Cancer
; 130(6): 961-969, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38272963
2.
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
Br J Cancer
; 130(5): 808-818, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38225422
3.
Model-Informed Precision Dosing of Intravenous Busulfan in Thai Pediatrics Undergoing Hematopoietic Stem Cell Transplantation.
Ther Drug Monit
; 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38758634
4.
Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors?
Br J Clin Pharmacol
; 89(8): 2446-2457, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36918744
5.
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
Br J Clin Pharmacol
; 89(2): 762-772, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36104927
6.
Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
Int J Mol Sci
; 24(18)2023 Sep 20.
Article
in English
| MEDLINE | ID: mdl-37762649
7.
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Pharm Res
; 37(7): 147, 2020 Jul 16.
Article
in English
| MEDLINE | ID: mdl-32676789
8.
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.
Br J Clin Pharmacol
; 85(6): 1357-1366, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30811063
9.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30299429
10.
Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing.
Clin Chem Lab Med
; 62(6): e129-e131, 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38198224
11.
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Therapie
; 72(2): 205-215, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28262261
12.
Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Therapie
; 72(2): 185-192, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28237406
13.
Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
Invest New Drugs
; 34(1): 41-8, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26572909
14.
Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients.
Eur J Pharm Sci
; 199: 106809, 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38788907
15.
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.
Clin Pharmacol Ther
; 2024 Mar 18.
Article
in English
| MEDLINE | ID: mdl-38494911
16.
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
Eur J Cancer
; 181: 3-17, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36621118
17.
Reply to the letter addressed by Amr A. EL-Arabey "Dual function of OCT-2 and MATE1 in Cisplatin induced nephrotoxicity".
Pharmacol Res
; 119: 494, 2017 May.
Article
in English
| MEDLINE | ID: mdl-27890819
18.
Traitements personnalisés grâce à la pharmacogénétique : niveaux de preuve et de recommandations du Réseau national de pharmacogénétique (RNPGx).
Therapie
; 72(2): 175-183, 2017 Apr.
Article
in French
| MEDLINE | ID: mdl-28153355
19.
Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription.
Therapie
; 77(2): 171-183, 2022.
Article
in English
| MEDLINE | ID: mdl-34922740
20.
Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury.
Metabolites
; 12(9)2022 Sep 11.
Article
in English
| MEDLINE | ID: mdl-36144257